沙利文发布《2026年全球基因疗法行业发展蓝皮书》

沙利文发布《2026年全球基因疗法行业发展蓝皮书》

2026 Global Gene Therapy Industry Development Blue Book'

发布时间:2026/08/05

沙利文发布《2026年全球基因疗法行业发展蓝皮书

Frost & Sullivan Releases the " Global Gene Therapy Industry Development Blue Book "

 

沙利文发布《2026年全球基因疗法行业发展蓝皮书》旨在系统梳理全球基因疗法行业在技术突破、监管完善、资本投入和商业化落地共同推动下的发展现状与未来趋势。蓝皮书将围绕产业发展历程、核心分类、政策与资本动态、产业链上下游、病毒载体生产瓶颈、重点适应症临床进展、支付路径及市场格局等方面展开分析,重点识别基因疗法在载体技术、规模化生产、临床转化、商业化支付和监管体系中的关键挑战与发展机遇。通过链接产业链企业、投资机构和监管主体,蓝皮书将为企业技术布局、产品开发、产业化决策、国际合作及行业标准完善提供前瞻性的市场洞察与战略参考。

 

Frost & Sullivan’s release of the 2026 Global Gene Therapy Industry Development Blue Book aims to systematically review the current state and future trends of the global gene therapy industry, driven by concurrent advances in technological breakthroughs, regulatory improvements, capital investment, and commercial rollout. The Blue Book will analyze the industry’s development history, core classifications, policy and capital dynamics, upstream and downstream supply chains, viral vector production bottlenecks, clinical progress in key indications, reimbursement pathways, and competitive landscape, with a particular focus on identifying critical challenges and opportunities in vector technologies, scale-up manufacturing, clinical translation, commercial reimbursement, and regulatory frameworks. By connecting industry chain players, investment institutions, and regulatory bodies, the Blue Book seeks to provide forward-looking market insights and strategic references for corporate technology planning, product development, industrialization decisions, international collaboration, and the refinement of industry standards

 

点击以下链接,查看摘要版 报告:

 

如果您对《全球基因疗法行业发展蓝皮书》有进一步的研究需求,请联系我们:

沙利文 毛先生

E-mail: fred.mao@frost.com

《2026全球基因疗法行业发展蓝皮书》摘要版.pdf
download

立即下载


获取白皮书

沙利文发布《2026年全球基因疗法行业发展蓝皮书》

×
请选择职位类别
请选择
×
联系我们
联系我们
电话

业务咨询热线

(021) 54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×